Dr. Jonathan Wright, MD, the pioneer of Bioidentical Hormone Replacement Therapy, has discussed the concept of hyperaromatization, which  explains why estrogen dominance should also be considered by men. Hyperaromatization occurs when testosterone is overly aromatized or converted to estrogen, leading to a situation where testosterone is low and high estradiol is high. Both breast and prostate tissues have estrogen receptors so they respond to estrogen.

He further enumerates the symptoms associated with hyperaromatization (Table 1), such as low libido, being overweight and gynecomastia, of course. If you, or someone you know, have these symptoms, changes are hyperaromatization is involved and the testosterone-estrogen balance needs to be corrected.

To correct excess aromatization of testosterone to estradiol, Myomin is recommended. As seen in previous emails and publication, Myomin reduces aromatase expression as well as estradiol level (and estrone, too). Because the conversion of testosterone to estradiol is inhibited, testosterone levels will eventually normalize.

We have seen this in many case reports, such as the one from Dr. G. Depke, ND from California. He has a 52-year-old male patient with elevated estradiol and estrone levels. After 4 months on Myomin, both levels reduced to within normal range (Table 2).

TABLE 2. Myomin reduced Estrogen in Male Patient

Dr. B. Sanborn , DC of Michigan, also has an interesting report that illustrates estrogen's role in gynecomastia. He has a 16-year-old male patient with gynecomastia. True enough, his estradiol level was high at 300 pg/mL. His DHT (dihydrotestosterone) was high as well, suggesting that his testosterone is progressively decreasing and being converted to both estradiol and DHT. After trying other supplements with no success, he finally tried Myomin and Prosta Chi. After 2 months, his estradiol and DHT levels reduced (Table 3). A significant in gynecomastia was also observed.

TABLE 3. Myomin reduced Estradiol and DHT in Gynecomastia Patient

In Dr. Sanborn's patient, Myomin effectively reduced estradiol. Prosta Chi is another supplement that works for the prostate by inhibiting the 5alpha reductase, the enzyme that converts testosterone to DHT. Achieving hormonal balance will eventually help completely resolve gynecomastia, such as in this case.

Dr. H. Lee, DMD from California, relates a similar case. A 35-year-old male patient was using finasteride (Propecia) for hair loss. Within 18 months, his hair showed much improved but he also found breast lumps. A mammogram found inflammation in his breast. He stopped finasteride and started on Myomin.

Myomin not only reduces estradiol but also increases testosterone level. This is again due to its aromatase reducer function, seen in the following case.

Dr. R. Ornelas, DC of California, has a 54-year-old male patient with low testosterone and high PSA levels. After a year of taking Myomin, Angiostop, Prosta Chi and Kidney Chi, both levels normalized.

TABLE 4. Myomin increases Testosterone and reduces PSA

Men who start to show signs of hyperaromatization should consider taking Myomin immediately to help correct the testosterone-estrogen imbalance. As you have seen in these cases, Myomin is effective in not just correcting the symptoms but also in resolving the underlying cause. Combining it with other supplements provides even better results. For prostate cancer, it is recommended with Angiostop and Revivin. For high PSA not due to cancer, Myomin is recommended with Prosta Chi and/or Kidney Chi.